Journal of Chemistry
Volume 2018 (2018), Article ID 5816906, 17 pages
https://doi.org/10.1155/2018/5816906

Research Article

Synthesis, Spectral Characterization, and Thermal and Cytotoxicity Studies of Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) Complexes of Schiff Base Derived from 5-Hydroxymethylfuran-2-carbaldehyde

Amani S. Alturiqi,¹ Abdel-Nasser M. A. Alaghaz,2,3 Reda A. Ammar,4,5 and Mohamed E. Zayed⁶

¹Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia
²Department of Chemistry, Faculty of Science, Jazan University, Jazan, Saudi Arabia
³Department of Chemistry, Faculty of Science (Boys), Al-Azhar University, Cairo, Egypt
⁴Department of Chemistry, College of Sciences Al Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia
⁵Department of Chemistry, Faculty of Science (Girls), Al-Azhar University, Cairo, Egypt
⁶Department of Botany and Microbiology, Faculty of Science, King Saud University, Riyadh 11541, Saudi Arabia

Correspondence should be addressed to Abdel-Nasser M. A. Alaghaz; aalajhaz@hotmail.com

Received 24 December 2017; Revised 18 February 2018; Accepted 8 March 2018; Published 9 May 2018

Academic Editor: Josefina Pons

Copyright © 2018 Amani S. Alturiqi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Coordination compounds of Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions were synthesized from the furan ligand [5-hydroxymethylfuran-2-yl-methyleneaminoquinolin-2-one] (H-MFMAQ) derived from the condensation of 5-hydroxymethylfuran-2-carbaldehyde and 1-aminoquinolin-2(1H)-one. Elemental analytical data, IR, NMR (¹H, ¹³C, and ¹⁵N), EPR, XRD, SEM, TEM, EDX, TGA, mass, molar conductance, magnetic moment, and UV-Visible spectra techniques were used to confirm the structure of the synthesized chelates. According to the data obtained, the composition of the 1 : 1 metal ions : furan Schiff base ligand was found to be [M(MFMAQ)Cl₂] (M = Cr(III) and Ru(III)) and [M(MFMAQ)Cl(H₂O)]·nH₂O in which (M = Mn(II); , Co(II); , Ni(II); , Cu(II); and Zn(II); ). The measurements of magnetic susceptibility, ligand field parameter, and reflectance spectra suggested an octahedral geometry for the complexes. Central metals ions and furan Schiff base coordinated via O3 and N donor sites which was observed from IR spectra. The cytotoxic activities of all inspected compounds were evaluated towards human breast (MCF-7) and lung cancer (A549) cell lines.

1. Introduction

Transition metal complexes derived from the Schiff base ligands with biological potency have been broadly studied. Schiff bases appear to be an important intermediate in a number of enzymatic reactions including interaction of an enzyme with an amino or a carbonyl group of the substrate. The biochemical process which involves the condensation of a primary amine in an enzyme may be one of the most important catalytic mechanisms kinds [1]. Transition metal complexes with different oxidation states have a strong role in bioinorganic chemistry and may give the models basis for active sites of biological systems [2–4]. For a long time, it had been identified as a serious cofactor in biological compounds, either as a compositional template in protein folding or as a Lewis acid catalyst which can readily adopt the coordination numbers 4, 5, or 6 [5, 6]. Coordination chemistry of cobalt complexes was a substantial importance as a result of the toxic environmental effect of cobalt. The cobalt mobilization and immobilization in the climate, organisms, and approximately technical systems (such as in ligand exchange chromatography) have been presented manifestly to depend on the complexation of the metal center by chelating nitrogen donor ligands [7]. The size and shape of the nanomaterials are considered the key factors for shaping their characteristics such as electrical, optical, magnetic, antimicrobial, and catalytic potency. Metal and metal oxide nanoparticles have found a wide range of uses, including heterogeneous catalysts, environmental remediation, electronics, chemical sensing devices, medicinal fields, separations, thin films, inks, disinfection, and antimicrobial activity [8]. These different applications altered with morphology and size of those metal and metal oxide nanoparticles [9]. Detection of metal ions of biological importance has attracted much attention. Like Zn²⁺ ion fluorescent probes or sensors have achieved special interest. Zn²⁺ is an essential trace element and the second (after Cu²⁺) most abundant metal ion in humans [10, 11]. In our present work, novel [M(MFMAQ)Cl₂] (M = Cr(III) and Ru(III)) and [M(MFMAQ)Cl(H₂O)]·H₂O (M = Mn(II); , Co(II); , Ni(II); , Cu(II); and Zn(II); ) complexes were discussed using different studding techniques such as elemental analyses, molar conductance, magnetic moment, and UV–Vis., IR, NMR (¹H, ¹³C and ¹⁵N), mass, EPR, XRD, SEM, TEM, EDX, and TGA behavior. Also, the ligand (H-MFMAQ) and its complexes show remarkable cytotoxicity against human breast (MCF-7) and lung cancer (A549) cell lines.

2. Experimental

2.1. Materials and Methods

All the metal salts were gained from E-Merck and used without further purification. Solvents MeOH, EtOH, DMF, DMSO, and agar were procured from Hi-media chemicals. However, the solvents were purified by the standard procedures. Elemental analyses were performed on a Perkin Elmer 2400 CH/N Analyzer. Metal contents were determined complexometrically by standard EDTA titration and the Cl was tested gravimetrically using AgNO₃. Electronic spectra of the complexes were recorded on a Shimadzu Model 1601 UV-Visible Spectrophotometer. Infrared spectroscopy measurements were performed on an Agilent Cary 630 FTIR spectrometer, using the Attenuated Total Reflectance (ATR) method, with a diamond cell. Spectra were recorded from 4000 to 400 cm–1, with 64 scans and resolution of 4 cm–1. The ¹H and correlation NMR spectra of samples were recorded in a Bruker Avance III 500 MHz (11.7 T) spectrometer. The ¹H NMR spectrum of samples was recorded in a Bruker Avance III 600 MHz (14 T) spectrometer. The NMR correlation spectrum of samples was recorded in a Bruker Avance III 400 MHz (9.4 T) spectrometer. The samples were analyzed in a d6-DMSO solution and the chemical shifts were given relative to tetramethylsilane (TMS). The ¹³C and ¹⁵N solid state NMR (SSNMR) spectra were recorded in a Bruker 300 MHz spectrometer, using the combination of cross-polarization, proton decoupling, and magic angle spinning (CP/MAS) at 10 kHz. Electrospray ionization mass spectrometry (ESI-MS) measurements were carried out using a Waters Quattro Micro API. Samples were evaluated in the positive mode. Ligand was analyzed in a 1 : 1 methanol : water solution with addition of 0.10% (v/v) formic acid; Cu(II) complex was analyzed in a 1 : 1 acetonitrile : water with 0.10% (v/v) formic acid; Co(II) and Ru(III) complexes were dissolved in a minimum amount of DMF and further dissolved in a 1 : 1 methanol : water solution with addition of 0.10% (v/v) formic acid immediately before the experiments. Each solution was directly infused into the instrument’s ESI source and analyzed in the positive mode, with capillary potential of 3.00 kV, trap potential of 2 kV, source temperature of 150°C, and nitrogen gas for desolvation. Room temperature magnetic susceptibility measurements were carried out on a modified Gouy-type magnetic balance, Hertz SG8-5HJ. The room temperature molar conductivity of the complexes in MeOH, EtOH, and DMSO solutions (0,001 mol·L⁻¹) was measured using a deep vision 601 model digital conductometer. The X-band EPR spectrum was performed at LNT (77 K) using TCNE as the g-marker. Powder X-ray diffraction patterns were recorded with a X’Pert PRO Diffractometer using CuK radiation (λ = 1.54060 Å) with operating voltage 40 kV and a current of 30 mA. Thermal studies were carried out using Q 600SDT and Q 20 DSC thermal analyzer. SEM images were recorded in a Hitachi SEM analyzer and transmission electron microscopy (TEM) images were taken by Zeiss-EM10C-100 KV. Energy Dispersive X-Ray Analysis (EDX) (EDAX Falcon System) was conducted to analyze the presence of elements in the specimens that have been sputtered with carbon black. The cytotoxic activity of the inspected free ligand and complexes (1–7) was studied towards human breast (MCF-7) and lung cancer (A549) cell lines at the Regional Center for Microbiology and Biotechnology, Al-Azhar University as well as the other biological activities.

2.2. Synthesis of Schiff Base Ligand (H-MFMAQ)

New Schiff base ligand (H-MFMAQ) (Scheme 1) was prepared when 5-hydroxymethylfuran-2-carbaldehyde (1.24 g, 11.23 mmol) was added to 1-aminoquinolin-2(1H)-one (1.79 g, 11.23 mmol), both dissolved in absolute ethanol (50 ml). Mixture was heated under reflux for 3 h to be a pale-yellow precipitate and was formed upon cooling the solution to room temperature. The product was filtered off and washed with few amounts of ethanol then diethyl ether, air-dried, and recrystallized from ethanol. The yield was 2.77 g (91%). The physical properties and analytical data of the furan Schiff base ligand and its metal complexes are scheduled in Table 1.

Table 1: Analytical and physical data of the ligand H-MFMAQ and complexes 1–7.

Number
Compound
(formula wt.) [M.Wt.]
Color
M.P.  °C
Yield%
Elemental analysis calc. (found)

C%
H%
N%
Cl%
M%

H-MFMAQ
(C₁₅H₁₂N₂O₃)  268.3
Pale yellow
146
91
67.16 (67.13)
4.51 (4.49)
10.44 (10.42)
- -
- -

1
[Cr(MFMAQ)Cl₂]
(H11Cl₂CrN₂O₃) 390.2
Dark brown
211
78
46.18 (46.12)
2.84 (2.82)
7.18 (7.14)
18.17 (18.11)
13.33 (13.32)

2
[Ru(MFMAQ)Cl₂]
(Cl₂N₂O₃Ru) 439.2
Black
219
83
41.02 (40.97)
2.52 (2.50)
6.38 (6.34)
16.14 (16.10)
23.01 (23.00)

3
[Mn(MFMAQ)Cl(H₂O)]·H₂O
(ClMnN₂O₅) 393.7
Wine red
224
82
45.76 (45.73)
3.84 (3.83)
7.12 (7.11)
9.00 (8.98)
13.95 (13.91)

4
[Co(MFMAQ)Cl(H₂O)]
(ClCoN₂O₄) 379.7
Olive
218
84
47.45 (47.42)
3.45 (3.43)
7.38 (7.33)
9.34 (9.32)
15.52 (15.50)

5
[Ni(MFMAQ)Cl(H₂O)]2H₂O
(ClN₂NiO₆) 415.5
Brown
226
77
43.37 (43.34)
4.12 (4.10)
6.74 (6.72)
8.53 (8.51)
14.13 (14.10)

6
[Cu(MFMAQ)Cl(H₂O)]
(ClCuN₂O₄) 384.3
Grass green
233
86
46.88 (46.83)
3.41 (3.38)
7.29 (7.23)
9.23 (9.20)
16.54 (16.51)

7
[Zn(MFMAQ)Cl(H₂O)]·2.5H₂O
(ClN₂Zn) 431.1
Yellow
208
73
41.79 (41.72)
4.21 (4.18)
6.50 (6.48)
8.22 (8.19)
15.16 (15.12)

Scheme 1: Synthetic route of ligand H-MFMAQ.

2.3. Synthesis of Schiff Base Metal(II/III) Complexes

A mixture of furan Schiff base ligand H-MFMAQ (6.76 mmol; 1.81 g) dissolved in an ethanol (20 ml) and chloride salt of Cr (III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), or Zn (II) (6.76 mmol) dissolved in the same solvent (20 ml) was heated for two hours under reflux on a water bath. The formed precipitate was filtered off, washed with ethanol and diethylether, and finally dried to give [Cr(MFMAQ)Cl₂] (1), [Ru(MFMAQ)Cl₂] (2), [Mn(MFMAQ)Cl(H₂O)]·H₂O (3), [Co(MFMAQ)Cl(H₂O)] (4), [Ni(MFMAQ)Cl(H₂O)]·2H₂O (5), [Cu(MFMAQ)Cl(H₂O)] (6), and [Zn(MFMAQ)Cl(H₂O)]·2.5H₂O (7) complexes.

3. Results and Discussions

3.1. Ligand (H-MFMAQ)

H-MFMAQ percentage of purity was 99.97%; it has been measured by HPLC. Mass spectrum of the furan Schiff base ligand (H-MFMAQ) (Figure 1(a)) has final peak at 268 amu corresponding to the furan Schiff base ligand moiety [C₁₅H₁₂N₂O₃] (atomic mass 268 amu) (Scheme 2). Other peaks like 52, 82, 148, 152, 208, and 227 amu were suggested according to diverse fragments. From this study, it was found that the intensity of the peaks gave information on the stability of fragmentation. The electronic spectrum of furan Schiff base ligand (H-MFMAQ) in ethanol exhibited five absorption bands (Figure 2(a)) at 233–338 nm regions which is due to and transitions utilizing molecular orbital of the quinoline and furan rings, C=N and C=O groups. Nevertheless, the IR spectrum of furan Schiff base ligand (H-MFMAQ) (Figure 3(a)) does not show any band at 1700 cm–1, 3380 cm–1, and 3250 cm–1 corresponding to the carbonyl groups and free primary amino groups; this confirms the complete condensation between keto and amino groups. The band at 1637 cm–1 is corresponding to (CH=N) stretching vibration. The IR spectrum of furan Schiff base ligand (H-MFMAQ) displays a broad band at 3483 cm–1, which can be assigned to ν(OH) group. The ¹H-NMR spectra of the furan Schiff base ligand (H-MFMAQ) (Figure 4(a)) exhibit signals due to aromatic protons as multiplet at δ 6.80–7.23 (8H) and a broad signal at δ (11.35) ppm is assigned for O–H proton, which disappeared with addition of D₂O due to the proton exchange. In ¹³C NMR of ligand (H-MFMAQ) (Figure 5(a)) (–C=O) carbonyl carbon showed signal at 166.47 ppm, (–C=N–) azomethine carbon at 162.12 ppm, (–C–O) phenolic group carbon at 158.27 ppm, and (C–O) furan ring at 170.12. The spectrum ¹5N-NMR of the ligand (H-MFMAQ) (Figure 6(a)) shows two signals centered 244.3 and 163.3 ppm, which were assigned to N12 (azomethine) and N1 (quinoline), respectively.

Scheme 2: Mass fragmentation pattern of furan Schiff base ligand (H-MFMAQ).

(a)

(b)

(c)

(d)

Figure 1: Mass spectrum of (a) ligand, (b) Co(II) complex, (c) Cu(II) complex, and (d) Ru(III) complex.

(a)

(b)

Figure 2: Electronic spectrum of (a) ligand and (b) Ru(III) complex.

(a) H-MFMAQ

(b) [Cr(MFMAQ)Cl₂]

(c) [Co(MFMAQ)Cl(H₂O)]

Figure 3: (a) IR spectrum of ligand, (b) IR spectrum of Cr(III) complex, and (c) IR spectrum of Zn(II) complex.

Figure 4: ¹H NMR spectra of (a) Schiff base ligand and (b) Zn(II) complex.

Figure 5: ¹³C NMR spectra of (a) Schiff base ligand and (b) Zn(II) complex.

Figure 6: ¹⁵N NMR spectra of (a) Schiff base ligand and (b) Zn (II) complex.

3.2. Complexes

The empirical formulae of complexes showing number of water molecules are presented in Table 1. All synthesized solid complexes are stable in air. They are practically insoluble in water, but on the contrary quite soluble in polar organic solvents (e.g., EtOH, MeOH, DMF, and DMSO). The structures of the complexes could not be determined because single crystals were not obtained. The molar conductivity data (Table 2) clearly indicate that all complexes in MeOH and DMSO as well as Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes in MeOH, DMF, and DMSO are in the range 7.58–15.24 Ω–1 cm2 mol–1 indicating the nonelectrolytic nature of all complexes [12]. This finding is consistent with the infrared spectral data that showed the coordinated nature of chloride anions.

Table 2: Molar conductivity of complexes Λ M/Ω⁻¹ cm² mol⁻¹ for 0,001 mol·L⁻¹ solutions in MeOH, DMF, and DMSO at 25°C.

Complex
  Ω⁻¹ cm² mol⁻¹

MeOH
DMF
DMSO

Cr(MFMAQ)Cl₂
14.36
15.24
7.58

Ru(MFMAQ)Cl₂
12.87
14.25
9.77

Mn(MFMAQ)Cl(H₂O)·H₂O
12.42
14.85
8.56

Co(MFMAQ)Cl(H₂O)
11.57
13.93
8.45

Ni(MFMAQ)Cl(H₂O)·2H₂O
12.84
14.47
9.27

Cu(MFMAQ)Cl(H₂O)
10.75
13.74
7.89

Zn(MFMAQ)Cl(H₂O)·2.5H₂O
11.59
14.66
8.98

3.2.1. Mass Spectra of Complexes

The ESI mass spectrum of the Co(II) complex [Co(MFMAQ)Cl(H₂O)] (Figure 1(b)) shows the parental ion peak at = 379 corresponding to (CoC₁₅H₁₃ClN₂O₄)⁺. The other fragments of the complex give the peak with various intensities at different values like at 74 (CoO)⁺, 77 (C₆H₅)⁺, 144 (CoC₄H₇NO)⁺, and 326 (CoC₁₅H₁₁N₂O₃)⁺. This schematic mass spectral fragmentation pattern of ligand is consistent with its structure which is depicted in Scheme 3.

Scheme 3: Mass fragmentation pattern of Co(II) complex [Co(MFMAQ)(H₂O)Cl].

The ESI mass spectrum of the Cu(II) complex [Cu(MFMAQ)Cl(H₂O)] (Figure 1(c)) shows the parental ion peak at = 384 corresponding to (CoC₁₅H₁₃ClN₂O₄)⁺. The different fragments of the complex with different values are present at 97 (C₅H₇NO)⁺, 120 (C₇H₈N₂)⁺, 202 (CuC₆H₇N₂O₂)⁺, and 326 (CuC₁₃H₁₁ClN₂O₂). This schematic mass spectral fragmentation pattern of ligand is consistent with its structure which is depicted in Scheme 4.

Scheme 4: Mass fragmentation pattern of Cu(II) complex [Cu(MFMAQ)(H₂O)Cl].

The ESI mass spectrum of the Ru(III) complex [Ru(MFMAQ)Cl₂] (Figure 1(d)) shows the molecular ion peak at = 439 corresponding to (RuC₁₅H₁₁Cl₂N₂O₃)+. The other fragments of the complex show the peaks at different values like at 56 (C₄H₈)⁺, 210 (RuC₆H₇NO)⁺, 158 (C₁₀H₁₀N₂)⁺, 263 (RuC₈H₆N₂O₂)⁺, and 326 (RuC₁₁H₁₄N₂OCl)⁺. This schematic mass spectral fragmentation pattern of ligand is consistent with its structure which is depicted in Scheme 5. These facts were matched to the suggested molecular formula for these complexes, that is, [Co(MFMAQ)Cl(H₂O)], [Cu(MFMAQ)Cl(H₂O)], and [Ru(MFMAQ)Cl₂], where MFMAQ is the ligand. This confirms the Schiff base frame formation. Elemental analysis values were appropriate with those values calculated from the molecular formulae assigned to these complexes which are further supported by mass studies.

Scheme 5: Mass fragmentation pattern of Ru(II) complex [Cu(MFMAQ)Cl₂].

3.2.2. Electronic Absorption, Magnetic Measurements, and Ligand Field Parameter

The electronic absorption spectra of the free Schiff base ligand and its complexes (Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II)) were studied in Nujol mull.

Two bands were showed at 18,995 ( = 46 Lmol⁻¹ cm⁻¹) and 16,238 cm–1 ( = 34 Lmol⁻¹ cm⁻¹); for Cr(III) complex [Cr(MFMAQ)Cl₂] electronic spectrum, those may be consigned to ⁴A₂g(F)→⁴T₁g(F) and ⁴A₂g(F)→⁴T₂g(F) transitions, respectively, in an octahedral geometry [13], whereas the third band, which is due to ⁴A₂g (F)→⁴T₁g (P) transition, lies in the range of the ligand transitions that were predicted at 34,264 cm–1 ( = 132 Lmol⁻¹ cm⁻¹). The ligand field parameters of the current Cr(III) complex have been calculated using Tanabe-Sugano diagrams (583 cm–1), 10 (1742 cm–1), and β (0.53). The effective magnetic moment of the complex is 3.92 BM, which is consistent with the spin-only value for three unpaired electrons (3.87 BM) [14].

Electronic spectrum of Mn(II) complex [Mn(MFMAQ)Cl(H₂O)]·H₂O exhibits four weak intensity absorption bands at 17,943 ( = 30 Lmol-1 cm⁻¹), 22,806 (ε = 36 Lmol⁻¹ cm⁻¹), 27,216 (ε = 64 mol⁻¹ cm⁻¹), and 37,489 cm⁻¹ (ε = 138 Lmol⁻¹ cm⁻¹). These bands may be assigned to the transitions: ⁶A₁g→⁴T₁g (4G), ⁶A₁g→ ⁴Eg, ⁴A₁g (4G) (10 + 5), ⁶A₁g→⁴Eg (4D) (17 + 5), and ⁶A₁g→ ⁴T₁g (4P) (7 + 7), respectively. The ligand parameters and were calculated from the second and third electronic transitions because these electronic transitions are free from the crystal field splitting and depend on and parameters [13, 14]. The calculated values of the ligand field parameters are given in Table 3. Room temperature magnetic moment of the Mn(II) complex lies at 5.94 BM; this value is in tune with a high-spin octahedral configuration.

Table 3: Ligand field parameters of the complexes.

Complex
Dq (cm⁻¹)
(cm⁻¹)
β
LFSE (kJmol⁻¹)

Cr(MFMAQ)Cl₂
1674
792
0.88
208.68

Ru(MFMAQ)Cl₂
–
–
–
–

Mn(MFMAQ)(H₂O)Cl·H₂O
1168
808
0.73
100.47

Co(MFMAQ)(H₂O)Cl
792
–
0.95
114.23

Ni(MFMQ)(H₂O)Cl·2H₂O
–
–
–
–

Cu(MFMAQ)Cl(H₂O)

492
0.81
–

Zn(MFMAQ)Cl(H₂O)2.5H₂O
–
–
–
–

The electronic spectrum of cobalt (II) complex [Co(MFMAQ)Cl(H₂O)] recorded in Nujol mulls exhibits three absorption peaks at 13,897 ( = 24 Lmol⁻¹ cm⁻¹), 15,368 ( = 27 Lmol⁻¹ cm⁻¹), and 25,157 ( = 53 Lmol⁻¹ cm⁻¹) cm–1, respectively. These bands can be assigned to ⁴T₁g→⁴T₂g (F)(), ⁴T₁g→⁴A₂g (F)(), and ⁴T₁g→⁴T₁g (P)() transitions, respectively, suggesting an octahedral geometry around Co(II) ion [13, 14]. Octahedral cobalt(II) complex, however, preserves a large orbital contribution to magnetic moment on account of ⁴T₁g (F) ground term and exhibits μeff in the range 4.8–5.6 B.M [15]. The magnetic measurements reported here lie at 5.18 BM and demonstrate that the Co(II) complex was paramagnetic and has a high-spin octahedral configuration with ⁴T₁g(F) ground state.

The ligand field parameters (Table 3) (interelectronic repulsion of the d-electrons in complex), β (The Nephelauxetic effect), and 10 are calculated according to the equation reported for the octahedral Co(II) complex.

where (free ion) for Co(II) is 996 cm⁻¹. The 10, , and β values are 7032 cm⁻¹, 698 cm⁻¹, and 0.68, respectively. These results show that the interelectronic repulsion of d-electrons in a complex is less than in the free ion. The value of in a complex is 78% of the free ion value. The β value is related directly to covalence.

The reduction of is caused by complex formation by the delocalization of the d-electron cloud on the ligand, which in turn causes the covalent bond formation. The data shows the Co(II) complex has covalent character in the metal ligand “” bond [15].

Electronic spectrum of [Ni(MFMAQ)Cl(H₂O)]·2H₂O complex shows bands at 15,053 ( = 23 Lmol⁻¹ cm⁻¹), 17,892 ( = 28 Lmol⁻¹ cm⁻¹), and 22,111 cm–1 (ε = 43 Lmol⁻¹ cm⁻¹). These bands may be specified to ₂g(F)→³T₂g(F)(), ³A₂g(F)→³T₁g(F)(), and ³A₂g(F)→³T₁g(P)() transitions, respectively. It proposes octahedral geometry of [Ni(MFMAQ)Cl(H₂O)]·2H₂O complex [13, 14]. The magnetic moment was evaluated which gave 3.08 μB, for [Ni(MFMAQ)Cl(H₂O)]·2H₂O complex which lies in the extent (2.9–3.3 μB) of the Ni(II) octahedral complexes [15]. The Nephelauxetic parameter β (Table 3) was readily obtained by utilizing the correlation β = (complex)/ (free ion), where (free ion) for Ni(II) is 1041 cm–1 [15]. The value of β lies at 0.27. These values indicated the covalent character in metal ligand “σ” bond [13].

The Cu(II) complex [Cu(MFMAQ)Cl(H₂O)] spectrum displayed a band at 22,137 cm⁻¹ ( = 41 Lmol⁻¹ cm⁻¹) assigned to ²Eg→²T₂g transition assuming octahedral geometry around the central Cu(II) ion [15]. The emulated magnetic moment of the Cu(II) complex is 1.98 BM, which assures the octahedral structure of this complex [15].

The electronic spectrum of ruthenium(III) complex [Ru(MFMAQ)Cl₂] records three bands at 15,167 () (ε = 22 Lmol⁻¹ cm⁻¹), 17,353 () (ε = 27 Lmol⁻¹ cm⁻¹), and 25,158 cm⁻¹ () (ε = 61 Lmol⁻¹ cm⁻¹) (Figure 2(b)). These bands may be assigned to ²T₂g→ ⁴T₁g, ²T₂g→ ⁴T₂g, and ²T₂g→⁴A₁g transitions in order of increasing energy. The position of bands is in tune with the prediction for octahedral complexes of the metal ions [13]. The ligand field parameters Δ, B, and β have been calculated by using the relation

The value of in free ion is 638 cm⁻¹. The value of β indicates that there is low covalency in the metal ligand σ-band [16]. The Ru(III) complex shows magnetic moments at room temperature 1.76 BM, which is lower than the predicted value of 2.17 BM. The lowering in values may be due to lower symmetry ligand fields, metal-metal interaction, or extensive electron delocalization [14].

The Zn(II) complex [Zn(MFMAQ)Cl(H₂O)]·2.5H₂O is diamagnetic as predictable and its geometry is most likely octahedral likewise Mn(II), Cu(II), Ni(II), and Co(II) complexes of H-MFMAQ ligand [15].

3.2.3. Infrared Spectra of Complexes

The study of infrared spectra of the furan Schiff base H-MFMAQ comparing to their metal complexes (1–7) (Table 4; Figure 3) foremost revealed that the ligand is tetradentately coordinated to the metal ions. The bands were symbolized at 1712 and 1637 cm–1 due to the carbonyl and azomethine stretching vibration which was shifted to lower frequency by 14–19 and 12–16 cm–1, suggesting oxygen carbonyl and nitrogen azomethine involvements in complexity. At 1618 cm–1, the band was assigned to the furan ring (C–O–C) vibrations which is also shifted to lower frequency by 13–18 cm–1, which is suggestive to involvement of the furan ring in chelation. Also, at 3483 cm–1, the band was attributed to OH in the ligand (H-MFMAQ) which disappeared in its metal complexes indicating deprotonation of the OH moiety during coordination [17]. The new bands at 543–552, 433–438, and 412–416 cm⁻¹ were assigned to M–O (carbonyl), M–O (phenol), M–N (azomethine) and (M–Cl) in the metal complexes spectra were observed [15, 17]. The IR results showed that the metal was harmonized through one nitrogen atom (azomethine group) and three oxygen atoms (deprotonated hydroxyl group, carbonyl group, and furan ring) besides chlorine atoms.

Table 4: IR spectral data (cm⁻¹) of the H-MFMAQ ligand and its metal complexes.

Number

H-MFMAQ
3483br
–
1712m
1637m
1618m
–
–
–

1
–
–
1693w
1621m
1600m
543m
433w
416m

2
–
–
1698m
1622m
1600w
548s
434w
412w

3
–
3320br
1695s
1622m
1605w
552m
438m
414m

4
–
3300r
1693m
1625sh
1602m
547m
434m
41 m

5
–
3320br
1697m
1624m
1605m
552m
437m
413m

6
–
3300r
1696m
1625m
1604m
549m
435m
414m

7
–
3318br
1698m
1623m
1603m
547m
438m
415m

sh: sharp, m: medium, br: broad, s: small, and w: weak.

3.2.4. NMR Spectra Investigation

The proton NMR spectroscopy of H-MFMAQ ligand (Figure 4(a)) and its [Zn(MFMAQ)Cl(H₂O)]2.5H₂O complex (Figure 4(b)) was evident in DMSO-d₆ solution employing tetramethylsilane (TMS) as internal standard. OH signal was found at 11.35 ppm in the spectrum of the ligand H-MFMAQ which completely disappeared in the spectrum of the [Zn(MFMAQ)Cl(H₂O)]2.5H₂O complex. This suggests the sharing of the OH group in chelation with Zn(II) through isolation of the OH proton. The azomethine proton signal was shifted to high field in the spectrum of [Zn(MFMAQ)Cl(H₂O)]2.5H₂O complex. It was looked at 8.13 ppm as compared to 8.67 ppm in the Schiff’s base H-MFMAQ. This refers to the complexity of the zinc atom through nitrogen atom azomethine. However, multiple bands assigned to the aromatic protons were found at 6.92–7.97 and 6.98–7.96 ppm in the free Schiff 22 base ligand and Zn(II) complex, respectively. The signal observed at 3.2 ppm with an integration corresponding to seven protons in the case of Zn(II) complex was assigned one coordinate water molecule and half past two hydrate water molecules.

In ¹³C NMR of ligand (Figure 5(a)) (–C=O) carbonyl carbon showed signal at 166.47 ppm, (–C=N–) azomethine carbon at 162.12 ppm, (–C–O) phenolic group carbon at 158.27 ppm, and (C–O) furan ring at 170.12. The signals due to (–C=N–) azomethine, (–C–O) phenolic, and (C–O) furan carbons were slightly shifted downfield in comparison to the corresponding signals of these groups in the ligand thereby confirming the complexation (Figure 5(b)) with zinc metal ion.

The ¹⁵N NMR spectra of the free ligand (Figure 6(a)) and the Zn(II) complex (Figure 6(b)) were also obtained. The spectrum of the ligand shows two signals centered at 244.3 and 163.3 ppm, which were assigned to N₁₂ (azomethine) and N₁ (quinoline), respectively. In the spectrum of Zn(II) complex only one broad signal is observed for the nitrogen atoms at 162.7 ppm. This behavior led us to assign the broad signal in the spectra of the complexes as both N₁₂ and N₁ atoms. With this assignment, N₁₂ shifted 81.6 ppm downfield upon coordination to Zn(II). On the other hand, the nitrogen N₁ shifts only 0.6 ppm upon coordination with Zn(II). This minor shift indicates that this atom is not involved in coordination as already evidenced by other techniques.

3.2.5. ESR Spectra

The ESR spectrum of the [Cr(MFMAQ)Cl₂] complex (Table 5) has been recorded as polycrystalline sample at room temperature. No hyperfine interaction was observed in the ESR spectra of the [Cr(MFMAQ)Cl₂] complex at room temperature. The -values are calculated by using the expression, = , where λ is the spin–orbit coupling constant for the metal ion in the complex. Owen [18] gives the reduction of the spin–orbit coupling constant from the free ion value; 90 cm⁻¹ for chromium(III) can be employed as a measure of metal ligand covalency (Figure 7(a)). It is possible to define a covalency parameter analogues to the Nephelauxetic parameter which is the ratio of the spin–orbit coupling constant for the complex and the free Cr(III) ions.

Table 5: The spin-Hamiltonian parameters of Cr(III) and Cu(II) Schiff base complexes in DMSO at 300 and 77 K.

Complex
Hyperfine constant × 10−4 cm⁻¹

Cr(MFMAQ)Cl₂
–
–
84
–
–
1.97

Cu(MFMAQ)Cl(H₂O)
163
47
106
2.34
2.04
2.11

(a)

(b)

Figure 7: EPR spectra of (a) Cr(III) complex and (b) Cu(II) complex as polycrystalline sample.

The solid state ESR spectrum of [Cu(MFMAQ)Cl] complex (Figure 7(b)) is displayed at room temperature. The shape of the spectrum is consistent with octahedral environment around Cu(II) ion and the higher value for the investigated [Cu(MFMAQ)Cl] complex (Table 5), when compared to that of free electron ( = 2.24) revealing an appreciable covalency of metal ligand bonding with as the ground-state characteristic of octahedral stereochemistry [19]. Also, the value 143 for the [Cu(MFMAQ)Cl] complex lies just within the range expected for octahedral complex [19]. The decrease of the -value by 9 compared to that of the free-electron value (2.07) is an approximate measure of the ligand field strength; the stronger the furan Schiff’s base ligand field, the smaller the decrease in the value and vice versa.

3.2.6. XRD, EDX, SEM, and TEM Morphological Studies

In Figure 8, XRD patterns of the [Cr(MFMAQ)Cl₂], [Co(MFMAQ)Cl(H₂O)], and [Cu(MFMAQ)Cl(H₂O)] complexes are depicted. The indexing procedures were performed using (CCP4, UK) CRYSFIRE program [20, 21] giving triclinic crystal system for [Cr(MFMAQ)Cl₂] (Figure 8(a)) having M(9) = 7, F(6) = 8, [Co(MFMAQ)Cl(H₂O)] orthorhombic crystal system (Figure 8(b)) having M(9) = 8, F(6) = 8, and tetragonal crystal system for [Cu(MFMAQ)Cl(H₂O)] (Figure 8(c)) having M(6) = 14, F(6) = 6, as the superior solutions. Their cell parameters are interpreted in Table 6.

Table 6: Crystallographic data for the Schiff base complexes [Cr(MFMAQ)Cl₂], [Co(MFMAQ)Cl(H₂O)], and [Cu(MFMAQ)Cl(H₂O)].

Data
Cr(MFMAQ)Cl₂
Co(MFMAQ)Cl(H₂O)
Cu(MFMAQ)Cl(H₂O)

Empirical formula
Cl₂O₃Cr
Cl₂N₂O₄Co
Cl₂N₂O₄Cu

Formula weight (g/mol)
390.2
379.7
384.3

Radiation
Cu-Kα1
Cu-Kα1
Cu-Kα1

2 range
5–60
5–60
5–60

Wavelength (Å)
1.501189
1.49997
1.52153

Crystal system
Triclinic
Orthorhombic
Tetragonal

Space group
P4/m
P4/m
P4/m

Unit cell dimensions (Å, °)

     (Å)
7.986878
17.2354
7.315829

     (Å)
8.000534
17.2362
7. 315829

     (°)
17.23584
16.2358
7. 315829

     (°)
90
90
90

     (°)
90
90
90

     (°)
90
90
90

Volume (Å³)
1010.47
5234.35
698.74

(Calc.) density (g/cm⁻³)
1.89785
1.34
1.89

Limiting indices
0 ≤ ≤ 3, 0 ≤ ≤ 1, 1 ≤ l ≤ 7
3 ≤ ≤ 10, 1 ≤ ≤ 6, 3 ≤ l ≤ 10
2 ≤ ≤ 8, 1 ≤ ≤ 8, 0 ≤ l ≤ 2

2
6
6

0.0000901
0.000027
0.0000783

Temperature (K)
298
298
298

(a)

(b)

(c)

Figure 8: Powder XRD spectra of (a) Cr(III), (b) Co(II), and (c) Cu(II) complexes.

The images SEM of [Cr(MFMAQ)Cl₂], [Ni(MFMAQ)Cl(H₂O)]·2H₂O, and [Cu(MFMAQ)Cl(H₂O)] complexes were showed in Figures 9(a)–9(c), respectively. The micrograph of [Cr(MFMAQ)Cl₂] complex shows peel shaped particles. The [Ni(MFMAQ)Cl(H₂O)]·2H₂O complex mentions ice rock structure. The [Cu(DPPMHQ)Cl(H₂O)] complex grain-structure of ice was existent. The chemical composition of Schiff base complexes was determined using energy dispersive X-ray diffraction (EDX). In EDX profile of Cr(III), Ni(II), and Cu(II) complexes (Figures 9(a)–9(c)) the peaks of essential elements like C, N, O and respective Cr(III), Ni(II), and Cu(II) elements which constitute the molecules of [Cr(MFMAQ)Cl₂], [Ni(MFMAQ)Cl(H₂O)]·2H₂O, and [Cu(MFMAQ)Cl(H₂O)] complexes are clearly identified supporting the proposed structures. All positions contain predictable elements, and different elements such as impurity were not detected.

(a)

(b)

(c)

Figure 9: The SEM/EDX images of (a): Cr(III), (b): Ni(II), and (c): Cu(II) complexes.

Figures 10(a)–10(c) show the TEM images of [Cr(MFMAQ)Cl₂], [Ni(MFMAQ)Cl(H₂O)]·2H₂O, and [Cu(MFMAQ)Cl(H₂O)] complexes, respectively. The consistency and resemblance in between the particle forms of synthesized dimeric complexes suggest that structural phases have a similar template. The particles diameter is found in nano range as follows: Cr(II), 62–224 nm; Ni(II), 18–23 nm; Cu(II), 12–32 nm. Nanoparticle-size complexes may act strong in different application areas in a biological one.

(a)

(b)

(c)

Figure 10: TEM images of (a): Cr(III), (b): Ni(II), and (c): Cu(II) complexes.

3.2.7. Thermal Decomposition

To evaluate the thermal behavior of metal complexes, the thermogravimetric (TG/DTG) curves for the complexes are represented in Figure 11 and weight loss at different decomposition stages, temperatures ranges with DTG peaks, assignments, and the final pyrolysis product observed in the present studies are summarized in Table 7.

Table 7: Thermal decomposition steps of the Cr(III), Ni(II), and Cu(II) complexes in TG plots.

Complex
Temperature
range (°C)
Weight loss (%)
DTG peaks
(°C)
Assignments
Residue found%
(calc.%)

Obs.
Cal.

[Cr(MFMAQ)Cl₂]
372–423
45.59
45.62
418
−C₆H₅NOCl₂
1/2Cr₂O₃  
19.71 (19.73)

473–798
34.88
34.90
544
−C₉H₆NO0.5

[Ni(MFMAQ)Cl(H₂O)]·2H₂O
92–194
12.87
12.99
122, 163
−2H₂O (hydrated) + H₂O (coordinated)
NiO
17.92 (17.97)

313–444
43.18
43.22
398
−C₉H₆NOCl

462–799
25.72
25.77
722
−C₆H₅NO

[Cu(MFMAQ)Cl(H₂O)]
192–273
4.62
4.68
249
−H₂O (coordinated)
CuO
20.63 (20.68)

293–484
46.95
46.99
326
−C₉H₇NOCl

506–798
27.58
27.61
565
−C₆H₄NO

Figure 11: TG and DTG 3D-plots of Cr(III), Ni(II), and Cu(II) complexes up to 800°C.

In TGA curve of the [Cr(MFMAQ)Cl₂] complex does not show any weight loss up to 385°C; this indicates the absence of lattice and coordinated water molecules in it. The [Cr(MFMAQ)Cl₂] complex shows two-step decomposition process in the range of 372–423°C and 473–798°C, respectively; the first step is relatively fast and a total of 26.84% weight loss has been observed which corresponds to the nonchelated part of the ligand moiety. The remaining chelated part of the ligand is decomposed in the second step which is 39.64% (calc. 38.46%). The final pyrolysis product, projected as chromium(III) oxide, and some unreacted residue had an observed mass of 33.52% (calc. 33.34%).

The TG curve of the [Ni(MFMAQ)Cl(H₂O)]·2H₂O complex shows the three-step decomposition process; in the first step 4.52% (calc. 4.23%) weight loss has been observed in the range of 92–124°C, which indicates the presence of one lattice water molecule in the complex. Another 4.86% (calc. 4.23%) weight loss corresponds to one coordinated water molecule which has been observed in the range of 124–173°C. In the second step of decomposition starting from 313°C to 442°C, nonchelated part of the ligand is eliminated which has been found to be 24.82% (calc. 26.04%). In the last step starting from 462°C to the final temperature, 46.84% (calc. 46.28%) weight loss corresponds to the remaining part of the ligand which has been noticed and the ultimate pyrolysis product is obtained as nickel(II) oxide of mass 18.96% (calc. 18.03%).

Quite similar results have been recorded for [Cu(MFMAQ)Cl(H₂O)] where decomposition takes place in three steps in the range of 192–273°C, 293–484°C, and 506–798°C, respectively, and copper (II) oxide; mass of 21.19% (calc. 19.78%) seems to be the final product. The only difference is that no lattice water molecule is presented in [Cu(MFMAQ)Cl(H₂O)] complex. On the basis of TG analysis the increasing order of the stability of complexes is as follows: [Ni(MFMAQ)Cl(H₂O)]·2H₂O < [Cu(MFMAQ)Cl(H₂O)] < [Cr(MFMAQ)Cl₂]. Thus, the Co(II) complex shows excellent thermal stability in all the complexes when subjected to higher temperature; hence it is used in such types of applications.

3.2.8. Structure of the Complexes

Based on the above studies, the following structure (Scheme 6) may suggest these complexes.

Scheme 6: The proposed structures of H-MFMAQ complexes.

3.2.9. Cytotoxicity Studies

The anticancer activities of the H-MFMAQ Schiff base ligand and its metal(II/III) complexes against the human breast (MCF-7) and lung cancer (A549) cell lines were screened using MTT assay. The results were analyzed by cell viability curves and expressed as IC₅₀ values. The maximal inhibition concentrations (IC₅₀) given in Table 8 showed that the cytotoxicity efficiencies of the compounds under investigation follow the order: Cr(III) complex > Ru(III) complex > H-MFMAQ > Mn(II) complex > Co(II) complex > Ni(II) complex > Cu(II) complex > Zn(II) complex. From the results, it is evident that the Cr(III) and Ru(III) complexes exhibited higher in vitro cytotoxicity against both the selected cell lines when compared to the Schiff base ligand. Also, the cytotoxicity efficiency of the Cr(III) and Ru(III) complexes is comparable with that of the standard drug, cis-platin, while the Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes showed lower anticancer activities when compared to that of the ligand. The cytotoxicity of metal complexes is depending on their ability to bind DNA and damage its structure resulting in the impairment of its function, which is followed by replication and transcription processes inhibition and eventually cell death that is what we can suppose [22–26]. Thus, the relatively higher cytotoxicity exhibited by the Cr(III) and Ru(III) complexes may be due to the relatively stronger binding ability of the complexes with DNA as shown in the DNA binding studies.

Table 8: Cytotoxicities (IC₅₀, μM) of the Schiff base ligand and its complexe.

Compound
MCF-7
A-549

Ligand

Cr(III) complex

Ru(III) complex

Mn(II) complex

Co(II) complex

Ni(II) complex

Cu(II) complex

Zn(II) complex

Cisplatin

IC₅₀: concentration of the drug required to inhibit growth of 50% of the cancer cells (μM). The data are mean ± SD of three replicates each.

4. Conclusion

The structures of the complexes of H-MFMAQ with Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) ions are confirmed by the elemental analyses, IR, NMR (¹H, ¹³C, and ¹⁵N) NMR, molar conductance, magnetic moment, UV–Vis., mass, ESR, SEM, EDX, TEM, and thermal analyses data. Therefore, from the IR spectra, it is concluded that H-MFMAQ behaves as a Schiff’s base tetradentate ligand with O₃N sites coordinating to the metal ions via the azomethine N group, furan O ring, carbonyl O group, and deprotonated hydroxyl-O group. From the molar conductance data of the complexes (), it is concluded that the complexes of H-MFMAQ ligand are considered as nonelectrolytes. Octahedral geometry was proposed to the Cr(III), Ru(III), Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes. The ¹H NMR spectra of the free ligand show that the –OH signal which appeared in the spectrum of H-MFMAQ ligand at 11.35 ppm completely disappeared in the spectra of its Zn(II) complex indicating that the –OH proton is removed by the chelation with Zn(II) ion. The antitumor activities of all inspected compounds were evaluated towards human breast (MCF-7) and lung cancer (A549) cell lines.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

This work was funded by the Deanship of Scientific Research at Princess Nourah Bint Abdulrahman University, through the Research Groups Program (Grant no. RGP-1438-00….).

References

B. Zhang, S. Li, E. Herdtweck, and F. E. Kühn, “Schiff base complexes of methyltrioxorhenium (VII): Synthesis and catalytic application,” Journal of Organometallic Chemistry, vol. 739, pp. 63–68, 2013.

M. K. Taylor, J. Reglinski, and D. Wallace, “Coordination geometry of tetradentate Schiff's base nickel complexes: The effects of donors, backbone length and hydrogenation,” Polyhedron, vol. 23, no. 18, pp. 3201–3209, 2004.

H.-C. Wu, P. Thanasekaran, C.-H. Tsai et al., “Self-assembly, reorganization, and photophysical properties of silver(I)-Schiff-base molecular rectangle and polymeric array species,” Inorganic Chemistry, vol. 45, no. 1, pp. 295–303, 2006.

E. Kwiatkowski, G. Romanowski, W. Nowicki, M. Kwiatkowski, and K. Suwińska, “Chiral dioxovanadium(V) complexes with single condensation products of 1,2-diaminocyclohexane and aromatic o-hydroxycarbonyl compounds: synthesis, characterization, catalytic properties and structure,” Polyhedron, vol. 26, no. 12, pp. 2559–2568, 2007.

N. K. Chaudhary and P. Mishra, “Metal complexes of a novel schiff base based on penicillin: characterization, molecular modeling, and antibacterial activity study,” Bioinorganic Chemistry and Applications, vol. 2017, Article ID 6927675, 13 pages, 2017.

N. A. Negm, M. F. Zaki, and M. A. I. Salem, “Cationic schiff base amphiphiles and their metal complexes: Surface and biocidal activities against bacteria and fungi,” Colloids and Surfaces B: Biointerfaces, vol. 77, no. 1, pp. 96–103, 2010.

T. Arun, R. Subramanian, and N. Raman, “Novel bio-essential metal based complexes linked by heterocyclic ligand: Synthesis, structural elucidation, biological investigation and docking analysis,” Journal of Photochemistry and Photobiology B: Biology, vol. 154, pp. 67–76, 2016.

A. Y. Lukmantara, D. S. Kalinowski, N. Kumar, and D. R. Richardson, “Synthesis and biological evaluation of 2-benzoylpyridine thiosemicarbazones in a dimeric system: Structure-activity relationship studies on their anti-proliferative and iron chelation efficacy,” Journal of Inorganic Biochemistry, vol. 141, no. 1, pp. 43–54, 2014.

J. Hung and L. M. Werbel, “Investigations into the synthesis of 6-ethyl-5-(4-pyridinyl)-2,4-pyrimidinediamine as a potential antimalarial agent,” Journal of Heterocyclic Chemistry, vol. 21, no. 3, pp. 741–744, 1984.

M.-H. Wu and W.-D. Zou, “Electronic structure of the organic half-metallic magnet: 2-(5-pyrimidinyl)-4,4,5,5-tetramethyl-4,5-dihydro-1 H-3-oxoimidazol-1-oxyl,” Journal of Mathematical Chemistry, vol. 40, no. 3, pp. 319–325, 2006.

H. Bayrak, A. Demirbas, S. A. Karaoglu, and N. Demirbas, “Synthesis of some new 1,2,4-triazoles, their Mannich and Schiff bases and evaluation of their antimicrobial activities,” European Journal of Medicinal Chemistry, vol. 44, no. 3, pp. 1057–1066, 2009.

W. J. Geary, “The use of conductivity measurements in organic solvents for the characterisation of coordination compounds,” Coordination Chemistry Reviews, vol. 7, no. 1, pp. 81–122, 1971.

R. F. M. Elshaarawy, Z. H. Kheiralla, A. A. Rushdy, and C. Janiak, “New water soluble bis-imidazolium salts with a saldach scaffold: Synthesis, characterization and in vitro cytotoxicity/bactericidal studies,” Inorganica Chimica Acta, vol. 421, pp. 110–122, 2014.

J. A. Faniran, K. S. Patel, and L. O. Nelson, “Physico-chemical studies of metal β-diketonates-I Infrared spectra of 1-(3-pyridyl)-1,3-butanedione and its divalent metal complexes,” Journal of Inorganic and Nuclear Chemistry, vol. 38, no. 1, pp. 77–80, 1976.

N. Raman, J. Dhaveethu Raja, and A. Sakthivel, “Template synthesis of novel 14-membered tetraazamacrocyclic transition metal complexes: DNA cleavage and antimicrobial studies,” Journal of the Chilean Chemical Society, vol. 53, no. 3, pp. 1568–1571, 2008.

A. Kumar, A. K. Jha, N. Mazumdar, S. N. Yadav, and L. K. Mishra, “Complexes of Nickel-, Zinc-, Palladium- And Cadmium(II) with some Furan-2-thiohydrazones,” Journal of the Indian Dental Association, vol. 74, no. 6, pp. 485-486, 1997.

K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, John Wiley & Sons, Inc, NY, USA, 2009.

J. Owen, “The magnetic evidence for charge transfer in octahedral complexes,” Discussions of the Faraday Society, vol. 19, pp. 127–134, 1955.

H. Montgomery and E. C. Lingafelter, “The crystal structure of Tutton's salts. IV. Cadmium ammonium sulfate hexahydrate,” Acta Crystallographica, vol. 20, no. 6, pp. 728–730, 1966.

R. Shirley, The crysfire system for automatic powder indexing: userís manual, The Lattice Press, Guildford Park Avenue, Guildford, Surrey GU2 7NL, England,UK, 2000.

A.-N. M. A. Alaghaz, M. E. Zayed, S. A. Alharbi, R. A. A. Ammar, and A. Chinnathambi, “Synthesis, spectroscopic identification, thermal, potentiometric and antibacterial activity studies of 4-amino-5-mercapto-S-triazole Schiff's base complexes,” Journal of Molecular Structure, vol. 1087, pp. 60–67, 2015.

F. Denizot and R. Lang, “Rapid colorimetric assay for cell growth and survival—modifications to the tetrazolium dye procedure giving improved sensitivity and reliability,” Journal of Immunological Methods, vol. 89, no. 2, pp. 271–277, 1986.

T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55–63, 1983.

E. Gao, Y. Sun, Q. Liu, and L. Duan, “An anticancer metallobenzylmalonate: Crystal structure and anticancer activity of a palladium complex of 2,2′-bipyridine and benzylmalonate,” Journal of Coordination Chemistry, vol. 59, no. 11, pp. 1295–1300, 2006.

M. Ferrari, M. C. Fornasiero, and A. M. Isetta, “MTT colorimetric assay for testing macrophage cytotoxic activity in vitro,” Journal of Immunological Methods, vol. 131, no. 2, pp. 165–172, 1990.

N. A. Rey, A. Neves, P. P. Silva et al., “A synthetic dinuclear copper(II) hydrolase and its potential as antitumoral: Cytotoxicity, cellular uptake, and DNA cleavage,” Journal of Inorganic Biochemistry, vol. 103, no. 10, pp. 1323–1330, 2009.